Trulieve Cannabis is trading 4.27% up at $11.47 on October 22, 2026; available reporting identifies no clear company-specific catalyst.
- Shares are rising while broader U.S. markets are lower, which does not explain the move.
- The November 5 earnings date is upcoming; no results were released today.
- The DEA rescheduling proceeding remains stayed, but coverage does not connect it to the gain.